-
-
-
-
-
-
-
Assembly Biosciences (ASMB) Misses Q1 EPS by 54c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Assembly Biosciences (ASMB)
-
-
-
-
-
-
-
Assembly Biosciences (ASMB) Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B
-
-
-
-
-
-
-
Assembly Biosciences (ASMB) Misses Q3 EPS by 151c
-
-
-
-
-
-
460,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

